OBJECTIVE: To evaluate clinical-pathological aspects of mitotically active @entity2909 . STUDY DESIGN: Twenty @entity1 with smooth @entity11090 of the uterus, with 5-9 mitotic figures per 10 high power fields and without atypia or @entity39 were studied. The clinical and pathological characteristics of these @entity5 were reviewed and analyzed. RESULTS: @entity1 ' ages ranged from 33 to 63 years (mean 42.5 years). The size of the @entity5 ranged from 1.5 to 9.5 cm (mean 5.4 cm). On gross examination all @entity5 appeared as typical @entity2909 . Treatment included hysterectomy in 16 @entity1 and myomectomy in four. Follow-up periods ranged from 1.5 to 11 years (mean 6.8 years). None of the @entity1 developed a recurrent @entity5 . CONCLUSION: The benign clinical behavior of such @entity5 supports their current designation as mitotically active @entity2909 , thus deleting the previous misnomer 'smooth @entity11090 of uncertain malignant potential'. Myomectomy is an appropriate treatment, particularly in young @entity1 interested in reproduction.

Clinical-pathological study of uterine XXXX with high mitotic activity.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity11090 :: ('MESH:D019042', 'Disease') :: ['muscle tumors'] @entity2909 :: ('MESH:D007889', 'Disease') :: ['leiomyomas']
@entity2909 :: (MESH:D007889,Disease) :: ['leiomyomas']
